Items Tagged ‘Medicare’

December 14th, 2015

Prospective Study Shows Age Doesn’t Affect Survival Outcomes in Patients with Myelodysplastic Syndrome (MDS) Who Receive a Hematopoietic Cell Transplant (HCT)


Results from a prospective study of 1,280 patients with myelodysplastic syndrome (MDS) showed that survival at 100 days and at two years following hematopoietic cell transplant (HCT) for patients aged 65 and older is comparable to patients aged 55 to 64. The study demonstrates that age alone should not be a determinant when considering HCT […]

View full entry

Tags: HCT, hematopoietic cell transplant, MDS, Medicare, Myelodysplastic Syndrome, News, Stem Cell Transplant